Issue 12, 2013

A graphene oxide–photosensitizer complex as an enzyme-activatable theranostic agent

Abstract

The development of a target-activatable “smart” platform with high-affinity and specificity is of great importance for a wide range of biomedical applications. Here, we attempted to develop a new enzyme-activatable graphene oxide–photosensitizer complex as a biologically tunable theranostic agent, making it promising for near-infrared (NIR) fluorescence imaging and photo-induced cancer therapy.

Graphical abstract: A graphene oxide–photosensitizer complex as an enzyme-activatable theranostic agent

Supplementary files

Article information

Article type
Communication
Submitted
30 Aug 2012
Accepted
18 Dec 2012
First published
18 Dec 2012

Chem. Commun., 2013,49, 1202-1204

A graphene oxide–photosensitizer complex as an enzyme-activatable theranostic agent

Y. Cho, H. Kim and Y. Choi, Chem. Commun., 2013, 49, 1202 DOI: 10.1039/C2CC36297J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements